The role of renal replacement therapy quantification in acute renal failure

W. R. Clark, B. A. Mueller, Michael Kraus, W. L. Macias

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. The optimal technique for RRT quantification in ARF remains to be determined.

Original languageEnglish (US)
JournalAmerican Journal of Kidney Diseases
Volume30
Issue number5 SUPPL.
StatePublished - 1997
Externally publishedYes

Fingerprint

Renal Replacement Therapy
Acute Kidney Injury
Chronic Kidney Failure
Renal Dialysis
Prescriptions
Research Personnel
Morbidity
Mortality

Keywords

  • Acute renal failure
  • Azotemia
  • Hemodialysis
  • Hemofiltration
  • Prescription

ASJC Scopus subject areas

  • Nephrology

Cite this

Clark, W. R., Mueller, B. A., Kraus, M., & Macias, W. L. (1997). The role of renal replacement therapy quantification in acute renal failure. American Journal of Kidney Diseases, 30(5 SUPPL.).

The role of renal replacement therapy quantification in acute renal failure. / Clark, W. R.; Mueller, B. A.; Kraus, Michael; Macias, W. L.

In: American Journal of Kidney Diseases, Vol. 30, No. 5 SUPPL., 1997.

Research output: Contribution to journalArticle

Clark, WR, Mueller, BA, Kraus, M & Macias, WL 1997, 'The role of renal replacement therapy quantification in acute renal failure', American Journal of Kidney Diseases, vol. 30, no. 5 SUPPL..
Clark, W. R. ; Mueller, B. A. ; Kraus, Michael ; Macias, W. L. / The role of renal replacement therapy quantification in acute renal failure. In: American Journal of Kidney Diseases. 1997 ; Vol. 30, No. 5 SUPPL.
@article{59e0a3f4dc2b41409e29852e84e52825,
title = "The role of renal replacement therapy quantification in acute renal failure",
abstract = "The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. The optimal technique for RRT quantification in ARF remains to be determined.",
keywords = "Acute renal failure, Azotemia, Hemodialysis, Hemofiltration, Prescription",
author = "Clark, {W. R.} and Mueller, {B. A.} and Michael Kraus and Macias, {W. L.}",
year = "1997",
language = "English (US)",
volume = "30",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5 SUPPL.",

}

TY - JOUR

T1 - The role of renal replacement therapy quantification in acute renal failure

AU - Clark, W. R.

AU - Mueller, B. A.

AU - Kraus, Michael

AU - Macias, W. L.

PY - 1997

Y1 - 1997

N2 - The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. The optimal technique for RRT quantification in ARF remains to be determined.

AB - The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. The optimal technique for RRT quantification in ARF remains to be determined.

KW - Acute renal failure

KW - Azotemia

KW - Hemodialysis

KW - Hemofiltration

KW - Prescription

UR - http://www.scopus.com/inward/record.url?scp=0030696223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030696223&partnerID=8YFLogxK

M3 - Article

C2 - 9372973

AN - SCOPUS:0030696223

VL - 30

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5 SUPPL.

ER -